136 related articles for article (PubMed ID: 16442531)
21. ZNF198, a zinc finger protein rearranged in myeloproliferative disease, localizes to the PML nuclear bodies and interacts with SUMO-1 and PML.
Kunapuli P; Kasyapa CS; Chin SF; Caldas C; Cowell JK
Exp Cell Res; 2006 Nov; 312(19):3739-51. PubMed ID: 17027752
[TBL] [Abstract][Full Text] [Related]
22. SUMO modification regulates the transcriptional activity of MAML1.
Lindberg MJ; Popko-Scibor AE; Hansson ML; Wallberg AE
FASEB J; 2010 Jul; 24(7):2396-404. PubMed ID: 20203086
[TBL] [Abstract][Full Text] [Related]
23. Sox5 and Sox6 are needed to develop and maintain source, columnar, and hypertrophic chondrocytes in the cartilage growth plate.
Smits P; Dy P; Mitra S; Lefebvre V
J Cell Biol; 2004 Mar; 164(5):747-58. PubMed ID: 14993235
[TBL] [Abstract][Full Text] [Related]
24. Modification of papillomavirus E2 proteins by the small ubiquitin-like modifier family members (SUMOs).
Wu YC; Roark AA; Bian XL; Wilson VG
Virology; 2008 Sep; 378(2):329-38. PubMed ID: 18619639
[TBL] [Abstract][Full Text] [Related]
25. Small ubiquitin-like modifier 1 (SUMO-1) modification of the synergy control motif of Ad4 binding protein/steroidogenic factor 1 (Ad4BP/SF-1) regulates synergistic transcription between Ad4BP/SF-1 and Sox9.
Komatsu T; Mizusaki H; Mukai T; Ogawa H; Baba D; Shirakawa M; Hatakeyama S; Nakayama KI; Yamamoto H; Kikuchi A; Morohashi K
Mol Endocrinol; 2004 Oct; 18(10):2451-62. PubMed ID: 15192080
[TBL] [Abstract][Full Text] [Related]
26. Transcription regulation of nuclear receptor PXR: Role of SUMO-1 modification and NDSM in receptor function.
Priyanka ; Kotiya D; Rana M; Subbarao N; Puri N; Tyagi RK
Mol Cell Endocrinol; 2016 Jan; 420():194-207. PubMed ID: 26549688
[TBL] [Abstract][Full Text] [Related]
27. The IL-6 family of cytokines modulates STAT3 activation by desumoylation of PML through SENP1 induction.
Ohbayashi N; Kawakami S; Muromoto R; Togi S; Ikeda O; Kamitani S; Sekine Y; Honjoh T; Matsuda T
Biochem Biophys Res Commun; 2008 Jul; 371(4):823-8. PubMed ID: 18474224
[TBL] [Abstract][Full Text] [Related]
28. Sox6 directly silences epsilon globin expression in definitive erythropoiesis.
Yi Z; Cohen-Barak O; Hagiwara N; Kingsley PD; Fuchs DA; Erickson DT; Epner EM; Palis J; Brilliant MH
PLoS Genet; 2006 Feb; 2(2):e14. PubMed ID: 16462943
[TBL] [Abstract][Full Text] [Related]
29. Sox6 is required for normal fiber type differentiation of fetal skeletal muscle in mice.
Hagiwara N; Yeh M; Liu A
Dev Dyn; 2007 Aug; 236(8):2062-76. PubMed ID: 17584907
[TBL] [Abstract][Full Text] [Related]
30. Association with class IIa histone deacetylases upregulates the sumoylation of MEF2 transcription factors.
Grégoire S; Yang XJ
Mol Cell Biol; 2005 Mar; 25(6):2273-87. PubMed ID: 15743823
[TBL] [Abstract][Full Text] [Related]
31. Ubc9-mediated sumoylation leads to transcriptional repression of IRF-1.
Kim EJ; Park JS; Um SJ
Biochem Biophys Res Commun; 2008 Dec; 377(3):952-6. PubMed ID: 18955028
[TBL] [Abstract][Full Text] [Related]
32. Daxx mediates SUMO-dependent transcriptional control and subnuclear compartmentalization.
Shih HM; Chang CC; Kuo HY; Lin DY
Biochem Soc Trans; 2007 Dec; 35(Pt 6):1397-400. PubMed ID: 18031230
[TBL] [Abstract][Full Text] [Related]
33. Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3.
Fu C; Ahmed K; Ding H; Ding X; Lan J; Yang Z; Miao Y; Zhu Y; Shi Y; Zhu J; Huang H; Yao X
Oncogene; 2005 Aug; 24(35):5401-13. PubMed ID: 15940266
[TBL] [Abstract][Full Text] [Related]
34. The DEAD-box protein DP103 (Ddx20 or Gemin-3) represses orphan nuclear receptor activity via SUMO modification.
Lee MB; Lebedeva LA; Suzawa M; Wadekar SA; Desclozeaux M; Ingraham HA
Mol Cell Biol; 2005 Mar; 25(5):1879-90. PubMed ID: 15713642
[TBL] [Abstract][Full Text] [Related]
35. SOX6 binds CtBP2 to repress transcription from the Fgf-3 promoter.
Murakami A; Ishida S; Thurlow J; Revest JM; Dickson C
Nucleic Acids Res; 2001 Aug; 29(16):3347-55. PubMed ID: 11504872
[TBL] [Abstract][Full Text] [Related]
36. SUMO-1 modification of PIASy, an E3 ligase, is necessary for PIASy-dependent activation of Tcf-4.
Ihara M; Yamamoto H; Kikuchi A
Mol Cell Biol; 2005 May; 25(9):3506-18. PubMed ID: 15831457
[TBL] [Abstract][Full Text] [Related]
37. Sox6 overexpression causes cellular aggregation and the neuronal differentiation of P19 embryonic carcinoma cells in the absence of retinoic acid.
Hamada-Kanazawa M; Ishikawa K; Nomoto K; Uozumi T; Kawai Y; Narahara M; Miyake M
FEBS Lett; 2004 Feb; 560(1-3):192-8. PubMed ID: 14988021
[TBL] [Abstract][Full Text] [Related]
38. SUMO-1 modification of the Wilms' tumor suppressor WT1.
Smolen GA; Vassileva MT; Wells J; Matunis MJ; Haber DA
Cancer Res; 2004 Nov; 64(21):7846-51. PubMed ID: 15520190
[TBL] [Abstract][Full Text] [Related]
39. Modification of nuclear PML protein by SUMO-1 regulates Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts.
Meinecke I; Cinski A; Baier A; Peters MA; Dankbar B; Wille A; Drynda A; Mendoza H; Gay RE; Hay RT; Ink B; Gay S; Pap T
Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5073-8. PubMed ID: 17360386
[TBL] [Abstract][Full Text] [Related]
40. Repression of the Transactivating Capacity of the Oncoprotein PLAG1 by SUMOylation.
Van Dyck F; Delvaux EL; Van de Ven WJ; Chavez MV
J Biol Chem; 2004 Aug; 279(34):36121-31. PubMed ID: 15208321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
